First Trust Advisors’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-22,771
| Closed | -$114K | – | 2536 |
|
|
2021
Q4 | $114K | Buy |
22,771
+346
| +2% | +$1.73K | ﹤0.01% | 2496 |
|
|
2021
Q3 | $270K | Buy |
22,425
+12,184
| +119% | +$147K | ﹤0.01% | 2403 |
|
|
2021
Q2 | $217K | Buy |
10,241
+784
| +8% | +$16.6K | ﹤0.01% | 2415 |
|
|
2021
Q1 | $265K | Sell |
9,457
-26,634
| -74% | -$746K | ﹤0.01% | 2340 |
|
|
2020
Q4 | $938K | Buy |
36,091
+21,067
| +140% | +$548K | ﹤0.01% | 1918 |
|
|
2020
Q3 | $558K | Buy |
15,024
+10,699
| +247% | +$397K | ﹤0.01% | 2005 |
|
|
2020
Q2 | $222K | Buy |
+4,325
| New | +$222K | ﹤0.01% | 2221 |
|
|
2017
Q4 | – | Sell |
-9,205
| Closed | -$461K | – | 2410 |
|
|
2017
Q3 | $461K | Sell |
9,205
-468
| -5% | -$23.4K | ﹤0.01% | 2114 |
|
|
2017
Q2 | $448K | Sell |
9,673
-10,529
| -52% | -$488K | ﹤0.01% | 2110 |
|
|
2017
Q1 | $713K | Buy |
+20,202
| New | +$713K | ﹤0.01% | 1956 |
|